|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Amortization of debt discount and issuance costs | |||||
| Amortization of finance right-of-use assets | |||||
| Amortization of operating right-of-use assets | |||||
| Deferred income taxes | |||||
| Amortization of premium and accretion of discount on short-term investments, net | |||||
| Realized and unrealized loss (gain) on financial instruments, net | |||||
| Unrealized foreign exchange loss (gain) | |||||
| Change in operating assets and liabilities, net of effects of business combinations: | |||||
| Accounts receivable, net | |||||
| Prepaid expenses and other current assets | |||||
| Deferred commissions | |||||
| Other long-term assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Operating lease liabilities | |||||
| Deferred revenue | |||||
| Other liabilities, non-current | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property, equipment and other assets | |||||
| Investments in non-marketable securities | |||||
| Business combinations, net of cash acquired | |||||
| Proceeds from the sales of marketable securities | |||||
| Proceeds from maturities of marketable securities | |||||
| Purchases of marketable securities | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of common stock, net of issuance costs | |||||
| Repurchase of early exercised stock options | |||||
| Proceeds from settlement of capped calls and other | |||||
| Repayments of convertible senior notes attributable to principal | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from the issuance of common stock under the Employee Stock Purchase Plan | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Principal payments of finance leases | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
| Supplemental cash flow disclosure | |||||
| Cash paid during the period for: | |||||
| Income taxes, net of refunds | |||||
| Interest expense | |||||
| Non-cash investing and financing activities: | |||||
| Vesting of early exercised stock options | |||||
| Issuance of common stock in connection with a business combination | |||||
| Common stock issued for conversion of convertible notes | |||||
| Settlement of capped calls | |||||
| Purchases of property and equipment included in accounts payable and accrued liabilities | |||||
| Unpaid taxes for net share settlement of equity awards included in accrued compensation and benefits | |||||
Loading...